Whole Body Health Sale

Heavy Metal Detoxification References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Glanze, W.D. Mosby Medical Encyclopedia, Revised Edition 1996. St. Louis, MO: C.V. Mosby.
  2. International Occupational Safety and Health Information Centre (CIS). Metals. In Basics of Chemical Safety, Chapter 7, 1999 Sep. Geneva: International Labour Organization.
  3. Ferner, D.J. Toxicity, heavy metals. eMed. J. 2001 May 25; 2(5): 1.
  4. Dupler, D. Heavy metal poisoning. Gale Encyclopedia of Alternative Medicine 2001. Farmington Hills, MI: Gale Group.
  5. Lide, D. CRC Handbook of Chemistry and Physics, 73rd Edition 1992. Boca Raton, FL: CRC Press.
  6. Roberts, J.R. Metal toxicity in children. In Training Manual on Pediatric Environmental Health: Putting It into Practice 1999 Jun. Emeryville, CA: Children's Environmental Health Network (http://www.cehn.org/cehn/trainingmanual/pdf/manual-full.pdf).
  7. Smith, S.R., Jaffe, D.M., Skinner, M.A. Case report of metallic mercury injury. Pediatr. Emer. Care 1997; 13: 114-6.
  8. Lupton, G.P., Kao, G.F., Johnson, F.B., Graham, J.H., Helwig, E.B. Cutaneous mercury granuloma. A clinicopathologic study and review of the literature. J. Am. Acad. Dermatol. 1985 Feb; 12(2, Pt. 1): 296-303.
  9. ATSDR Mission Statement (2001)
  10. ToxFAQs™ for Arsenic. CAS 7440-38-2 2001 Jul. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
  11. ToxFAQs™ for Lead. CAS 7439-92-1 1999 Jun. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
  12. Goyer, R.A. Toxic effects of metals: mercury. Casarett and Doull's Toxicology: The Basic Science of Poisons, Fifth Edition 1996. New York: McGraw-Hill.
  13. Clarkson, T.W. Mercury: an element of mystery. N. Engl. J. Med. 1990; 323: 1137-9.
  14. Omura, Y., Shimotsuura, Y., Fukuoka, A., Fukuoka, H., Nomoto, T. Significant mercury deposits in internal organs following the removal of dental amalgam, and development of pre-cancer on the gingiva and the sides of the tongue and their represented organs as a result of inadvertent exposure to strong curing light (used to solidify synthetic dental filling material) and effective treatment: a clinical case report, along with organ representation areas for each tooth. Acupunct. Electrother. Res. 1996; 1(2): 133-60.
  15. O'Brien, J. Mercury amalgam toxicity. Life Extension Magazine 2001 May. 7(5): 43-51. Ft. Lauderdale, FL: Life Extension Foundation (http://www.lef.org/magazine/mag2001/may2001_report_mercury_1.html).
  16. ToxFAQs™ for Mercury. CAS 7439-97-6 1999 Apr. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
  17. ToxFAQs™ for Cadmium. CAS 7440-43-9 1999 Jun. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
  18. ToxFAQs™ for Aluminum. CAS 7429-90-5 1999 Jun. Atlanta, GA: Agency for Toxic Substances and Disease Registry.
  19. Anon. Alzheimer's and aluminum: canning the myth. Food Insight 1993 Sep-Oct. Washington, D.C.: International Food Information Council Foundation.
  20. WHO. Aluminum. In Guidelines for Drinking-Water Quality, Second Edition, Addendum to Volume 2, Health Criteria and Other Supporting Information 1998, pp. 3-13. Geneva: World Health Organization.
  21. Brown, D.J. Characterizing Risk at Metal Finishing Facilities. Report EPA/600/R-97/111 May 1998. Washington, D.C.: U.S. Environmental Protection Agency.
  22. Bardin, J.A., Eisen, E.E., Wegman, D.H., Kriebel, D., Woskie, S.R., Gore, R.J. Case-Control Studies of Liver, Gallbladder and Pancreatic Cancer and Metalworking Fluid Exposure in the Automobile Industry; presented to the 128th Annual Meeting of the American Public Health Association, November 14, 2000. Washington, D.C.: American Public Health Association.
  23. ATSDR MMGs and ToxFAQs
  24. Zayas, L. Ozuah, P. Mercury use in espiritismo: a survey of botanicas. Am. J. Public Health 1996; 86: 111-2.
  25. Ewan, K., Pamphlett, R. Increased inorganic mercury in spinal motor neurons following chelating agents. Neurotoxicology 1996; 17(2): 343-9.
  26. Vimy, M.J., Takahashi, Y., Lorscheider, F.L. Maternal-fetal distribution of mercury (203Hg) released from dental amalgam fillings. Am. J. Physiol. 1990 Apr; 258(4, Pt. 2): R939-45.
  27. Willershausen-Zonnchen, B., Zimmermann, M., Defregger, A., Schramel, P., Hamm, G. Mercury concentration in the mouth mucosa of patients with amalgam fillings. Dtsch. Med. Wochenschr. 1992 Nov 13; 117(46): 1743-7 (in German).
  28. Gebel, T., Dunkelberg, H. Influence of chewing gum consumption and dental contact of amalgam fillings to different metal restorations on urine mercury content. Zentralbl. Hyg. Umweltmed. 1996 Nov; 199(1): 69-75 (in German).
  29. Sallsten, G., Thoren, J., Barregard, L., Schutz, A., Skarping, G. Long-term use of nicotine chewing gum and mercury exposure from dental amalgam fillings. J. Dent. Res. 1996 Jan; 75(1): 594-8.
  30. Isacsson, G., Barregard, L., Selden, A., Bodin, L. Impact of nocturnal bruxism on mercury uptake from dental amalgams. Eur. J. Oral Sci. 1997 Jun; 105(3): 251-7.
  31. Anderton, R.M. ADA Statement on Dental Amalgam 2001 May. Chicago, IL: American Dental Association.
  32. ADA. American Dental Association. Statement on Dental Amalgam. Available at: http://www.ada.org/1741.aspx. Last updated August 25, 2009. Accessed October 9, 2012.
  33. Saxe, S.R., Wekstein, M.W., Kryscio, R.J., Henry, R.G., Cornett, C.R., Snowdon, D.A., Grant, F.T., Schmitt, F.A., Donegan, S.J., Wekstein, D.R., Ehmann, W.D., Markesbery, W.R. Alzheimer's disease, dental amalgam and mercury. J. Am. Dent. Assoc. 1999 Feb; 130(2): 191-9.
  34. Dr. Joseph F. Smith Medical Library. Heavy Metal Poisoning 2001 Nov. Wassau, WI: Medical Library/Thomson.
  35. Medical Management Guidelines (MMGs): Managing Hazardous Material Incidents, Volume III 2001. Atlanta, GA: Agency for Toxic Substances and Disease Registry (http://www.atsdr.cdc.gov).
  36. Wentz, P.W. (LabCorp, Burlington, NC). Chelation therapy: conventional treatments. In Advance Magazines/Administrators of the Laboratory 2000 May. King of Prussia, PA: Merion (http://www.advanceforal.com/common/editorial/editorial/aspx).
  37. USNLM/NIH. Drug Information: Deferoxamine (Systemic) 2001a. Bethesda, MD: U.S.National Laboratory of Medicine/National Institutes of Health (http://www.nlm.nih.gov/medlineplus/druginfo).
  38. USNLM/NIH. Drug Information: DMSA (Succimer Systemic) 2001b. Bethesda, MD: U.S. National Laboratory of Medicine/National Institutes of Health (http://www.nlm.nih.gov/medlineplus/druginfo).
  39. USNLM/NIH. Drug Information: EDTA (Edetate Disodium Systemic) 2001c. Bethesda, MD: U.S. National Laboratory of Medicine/National Institutes of Health (http://www.nlm.nih.gov/medlineplus/druginfo).
  40. USNLM/NIH. Drug Information: Penicillamine (Systemic) 2001d. Bethesda, MD: U.S. National Laboratory of Medicine/National Institutes of Health (http://www.nlm.nih.gov/medlineplus/druginfo).
  41. Micromedex. B.A.L.™ 1999. Greenwood Village, CO: Thomson/Micromedex.
  42. Tripathi, N., Flora, S.J. Effects of some thiol chelators on enzymatic activities in blood, liver and kidneys of acute arsenic (III) exposed mice. Biomed. Environ. Sci. 1998 Mar; 11(1): 38-45.
  43. Aaseth, J., Jacobsen, D., Andersen, O., Wickstron, E. Treatment of mercury and lead poisonings with dimercaptosuccinic acid (DMSA) and sodium dimmercapto-propanesulfonate (DMPS). Analyst 1995 Mar; 120: 853ff; presented at the Fifth Nordic Symposium on Trace Elements in Human Health and Disease, Loen, Norway, June 19-20, 1994.
  44. FDA. DMPS 1999. Washington, D.C.: Food and Drug Administration (http://www.fda.gov/cder/fdama/pclist.txt).
  45. Marcus, S. Toxicity, lead. eMed. J. 2001 Jun 4; 2(6): 7.
  46. Klein-Schwartz, W., Oderda, G.M. Clinical toxicology. In Textbook of Therapeutics: Drug and Disease Management, Seventh Edition 2000, p. 51. Baltimore, MD: Williams & Wilkins.
  47. James, D. General Methods for Treating Poisoning 2001. Alberta, Canada: University of Alberta.
  48. Anon. Management of the Poisoned/Overdosed Patient (Continuing Education No. 430-000-99-026-H01). U.S. Pharmacist 2001. New York: Jobson.
  49. Fournier, L., Thomas, G., Garnier, R., Buisine, A., Houze, P., Pradier, F., Dally, S. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med. Toxicol. Adverse Drug Exp. 1988; 3: 499-504.
  50. National Medical Library. Poisoning first aid. In Medical Encyclopedia 2001. Bethesda, MD: National Institutes of Health (http://www.nlm.nih.gov/medlineplus/ency/article/000003.htm).
  51. Ghio, A.J., Kennedy, T.P., Crissman, K.M., Richards, J.H., Hatch, G.E. Depletion of iron and ascorbate in rodents diminishes lung injury after silica. Exp. Lung Res. 1998 Mar-Apr; 24(2): 219-32.
  52. Dhir, H., Roy, A.K., Sharma, A., Talukder, G. Modification of clastogenicity of lead and aluminium in mouse bone marrow cells by dietary ingestion of Phyllanthus emblica fruit extract. Mutat. Res. 1990 Jul; 241(3): 305-12.
  53. Dhir, H., Roy, A.K., Sharma, A. Relative efficiency of Phyllanthus emblica fruit extract and ascorbic acid in modifying lead and aluminium-induced sister-chromatid exchanges in mouse bone marrow. Environ. Mol. Mutagen 1993; 21(3): 229-36.
  54. West, W.L., Knight, E.M., Edwards, C.H., Manning, M., Spurlock, B., James, H., Johnson, A.A., Oyemade, U.J., Cole, O.J., Westney, O.E. et al. Maternal low level lead and pregnancy outcomes. J. Nutr. 1994 Jun; 124(6, Suppl.): 981S-986S.
  55. Vij, A.G., Satija, N.K., Flora, S.J. Lead induced disorders in hematopoietic and drug metabolizing enzyme system and their protection by ascorbic acid supplementation. Biomed. Environ. Sci. 1998 Mar; 11(1): 7-14.
  56. Cai, L., Koropatnick, J., Cherian, M.G. Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper. Chem. Biol. Interact. 2001 Jul 31; 137(1): 75-88.
  57. Pryor, W.A. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic. Biol. Med. 2000 Jan 1; 28(1): 141-64.
  58. Van Vleet, J.F., Boon, G.D., Ferrans, V.J. Induction of lesions of selenium-vitamin E deficiency in ducklings fed silver, copper, cobalt, tellurium, cadmium, or zinc: protection by selenium or vitamin E supplements. Am. J. Vet. Res. 1981 Jul; 42(7): 1206-17.
  59. Tandon, S.K., Singh, S., Dhawan, M. Preventive effect of vitamin E in cadmium intoxication. Biomed. Environ. Sci. 1992 Mar; 5(1): 39-45.
  60. Milchak, L.M., Douglas Bricker, J. The effects of glutathione and vitamin E on iron toxicity in isolated rat hepatocytes. Toxicol. Lett. 2002 Feb 7; 126(3): 169-77.
  61. Villamor, E., Fawzi, W.W. Vitamin A supplementation: implications for morbidity and mortality in children. J. Infect. Dis. 2000 Sep; 182(Suppl.1): S122-S133.
  62. Gurer, H., Ozgunes, H., Oztezcan, S., Ercal, N. Antioxidant role of alpha-lipoic acid in lead toxicity. Free Radic. Biol. Med. 1999 Jul; 27(1-2): 75-81.
  63. Anuradha, B., Varalakshmi, P. Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation. Pharmacol. Res. 1999 Jan; 39(1): 67-80.
  64. Muller, U., Krieglstein, J. Prolonged pretreatment with alpha-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J. Cereb. Blood Flow Metab. 1995 Jul; 15(4): 624-30.
  65. Muller, L. Protective effects of DL-alpha-lipoic acid on cadmium-induced deterioration of rat hepatocytes. Toxicology 1989 Oct 2; 58(2): 175-85.
  66. Muller, L., Menzel, H. Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium 2+ toxicity in isolated hepatocytes. Biochim. Biophys. Acta 1990 May 22; 1052(3): 386-91.
  67. Ringwood, A.H., Conners, D.E. The effects of glutathione depletion on reproductive success in oysters, Crassostrea virginica. Mar. Environ. Res. 2000 Jul-Dec; 50(1-5): 207-11.
  68. Chouchane, S., Snow, E.T. In vitro effect of arsenical compounds on glutathione-related enzymes. Chem. Res. Toxicol. 2001 May; 14(5): 517-22.
  69. Lorico, A., Bertola, A., Baum, C., Fodstad, O., Rappa, G. Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochem. Biophys. Res. Commun. 2002 Mar 1; 291(3): 617-22.
  70. Maiti, S., Chatterjee, A.K. Effects on levels of glutathione and some related enzymes in tissues after an acute arsenic exposure in rats and their relationship to dietary protein deficiency. Arch. Toxicol. 2001 Nov; 75(9): 531-7.
  71. Daggett, E.A., Oberley, T.D., Nelson, S.A., Wright, L.S., Kornguth, S.E., Siegel, F.L. Effects of lead on rat kidney and liver: GST expression and oxidative stress. Toxicology 1998 Jul 17; 128(3): 191-206.
  72. Wright, L.S., Kornguth, S.E., Oberley, T.D., Siegel, F.L. Effects of lead on glutathione S-transferase expression in rat kidney: a dose-response study. Toxicol. Sci. 1998 Dec; 46(2): 254-9.
  73. Shukla, G.S., Srivastava, R.S., Chandra, S.V. Glutathione status and cadmium neurotoxicity: studies in discrete brain regions of growing rats. Fundam. Appl. Toxicol. 1988 Aug; 11(2): 229-35.
  74. Turan, B., Delilbasi, E., Dalay, N., Sert, S., Afrasyap, L., Sayal, A. Serum selenium and glutathione-peroxidase activities and their interaction with toxic metals in dialysis and renal transplantation patients. Biol. Trace Elem. Res. 1992 Apr-Jun; 33: 95-102.
  75. Sidhu, M., Sharma, M., Bhatia, M., Awasthi, Y.C., Nath, R. Effect of chronic cadmium exposure on glutathione S-transferase and glutathione peroxidase activities in rhesus monkey: the role of selenium. Toxicology 1993 Oct 25; 83(1-3): 203-13.
  76. Tang, W., Sadovic, S., Shaikh, Z.A. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione. Toxicol. Appl. Pharmacol. 1998 Aug; 151(2): 276-82.
  77. Tjalkens, R.B., Valerio, L.G., Jr., Awasthi, Y.C., Petersen, D.R. Association of glutathione S-transferase isozyme-specific induction and lipid peroxidation in two inbred strains of mice subjected to chronic dietary iron overload. Toxicol. Appl. Pharmacol. 1998 Jul; 151(1): 174-81.
  78. Shaikh, Z.A., Northup, J.B., Vestergaard, P. Dependence of cadmium-metallothionein nephrotoxicity on glutathione. J. Toxicol. Environ. Health A 1999a; 57(3): 211-22.
  79. Brink, W. Lactoferrin: the bioactive peptide that fights disease. Life Extension Magazine 2000 Oct; 6(10): 20-6. Ft. Lauderdale, FL: Life Extension Foundation (http://www.lef.org/magazine/mag2000/oct2000_report_lactoferrin.html).
  80. Stella, V., Postaire, E. Evaluation of the antiradical protector effect of multifermented milk serum with reiterated dosage in rats. C. R. Seances Soc. Biol. Fil. 1995; 189(6): 1191-7 (in French).
  81. Girodon, F. Galan, P. Monget, A.L., Boutron-Ruault, M.C., Brunet-Lecomte, P., Preziosi, P., Arnaud, J., Manuguerra, J.C., Herchberg, S. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch. Intern. Med. 1999 Apr 12; 159(7): 748-54.
  82. Porter, J.M., Ivatury, R.R., Azimuddin, K., Swami, R. Antioxidant therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. Am. Surg. 1999 May; 65(5): 478-83; erratum, Am. Surg. 1999 Sep; 65(9): 902.
  83. Schumacher, K. Effect of selenium on the side effect profile of adjuvant chemotherapy/radiotherapy in patients with breast carcinoma. Design for a clinical study. Med. Klin. 1999 Oct 15; 94(Suppl. 3): 45-8 (in German).
  84. Leung, F.Y. Trace elements that act as antioxidants in parenteral micronutrition. Can. J. Nutr. Biochem. 1998; 9(6): 304-7.
  85. Pakdaman, A. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures. Biol. Trace Elem. Res. 1998 Apr-May; 62(1-2): 1-6.
  86. Huang, K.-C. The Pharmacology of Chinese Herbs 1993. Boca Raton, FL: CRC Press.
  87. Omura, Y., Beckman, S.L. Role of mercury (Hg) in resistant infections and effective treatment of Chlamydia trachomatis and Herpes family viral infections (and potential treatment for cancer) by removing localized Hg deposits with Chinese parsley and delivering effective antibiotics using various drug uptake enhancement methods. Acupunct. Electrother. Res. 1995; 20(3-4): 195-229.
  88. Cha, C.W. A study on the effect of garlic to the heavy metal poisoning of rat. J. Korean Med. Sci. 1987 Dec; 2(4): 213-24.
  89. Forester SC, Lambert JD. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res. 2011; 55(6):844-54.
  90. Clayman, C.B., Ed. The American Medical Association Encyclopedia of Medicine 1989. New York: Random House.
  91. Clayman, C.B., Ed. The American Medical Association Encyclopedia of Medicine 1989. New York: Random House.
  92. Quig, D. Cysteine metabolism and metal toxicity. Altern. Med. Rev. 1998 Aug; 3(4): 262-70.
  93. De Flora, S., Izzotti, A., D'Agostini, F., Balansky, R.M. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001 Jul; 22(7): 999-1013.
  94. Shaikh, Z.A., Tang, W. Protection against chronic cadmium toxicity by glycine. Toxicology 1999b Feb 15; 132(2-3): 139-46.
  95. Hipkiss AR, Preston JE, Himsworth DT, et al. Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann N Y Acad Sci. 1998 Nov 20;854:37-53.
  96. Hipkiss AR. On the enigma of carnosine’s anti-ageing actions. Exp Gerontol. 2009a Apr;44(4):237-42.
  97. Hipkiss AR. Carnosine and its possible roles in nutrition and health. Adv Food Nutr Res. 2009b;57:87-154.
  98. Boldyrev AA, Stvolinsky SL, Fedorova TN, Suslina ZA. Carnosine as a natural antioxidant and geroprotector: from molecular mechanisms to clinical trials. Rejuvenation Res. 2010 Apr-Jun;13(2-3):156-8.
  99. Suh JH, Zhu BZ, deSzoeke E, Frei B, Hagen TM. Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes. Redox Rep. 2004;9(1):57-61.
  100. Lal A, Atamna W, Killilea DW, Suh JH, Ames BN. Lipoic acid and acetyl-carnitine reverse iron-induced oxidative stress in human fibroblasts. Redox Rep. 2008;13(1):2-10.
  101. Smith-Barbaro, P., Hanson, D., Reddy, B.S. Carcinogen binding to various types of dietary fiber. J. Natl. Cancer Inst. 1981 Aug; 67(2): 495-7.
  102. Ichimura, S. Report. General meeting of the Pharmaceutical Society of Japan, Hokuriku Branch, Toyoma City, Japan, October 27, 1973.
  103. Horikoshi, T., Nakajima, A., and Sakaguchi, T. Uptake of uranium by various cell fractions of Chlorella regularis. Radioisotopes 1979 Aug; 28(8): 485-8.
  104. Prater, G. MSM: the multi-purpose compound. Life Extension Magazine 1999 Sep; 5(9): 71-2. Ft. Lauderdale, FL: Life Extension Foundation.
  105. Esteves, A.C., Felcman, J. Study of the effect of the administration of Cd(II), cysteine, methionine, and Cd(II) together with cysteine or methionine on the conversion of xanthine dehydrogenase into xanthine oxidase. Biol. Trace Elem. Res. 2000 Jul; 76(1): 19-30.
  106. Deschner, E.E., Ruperto, J.F., Wong, G.Y., Newmark, H.L. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr. Cancer 1993; 20(3): 199-204.
  107. Perez Guerrero, C., Martin, M.J., Marhuenda, E. Prevention by rutin of gastric lesions induced by ethanol in rats: role of endogenous prostaglandins. Gen. Pharmacol. 1994 May; 25(3): 575-80.
  108. Kostyuk, V.A., Potapovich, A.I., Speransky, S.D., Maslova, G.T. Protective effect of natural flavonoids on rat peritoneal macrophages injury caused by asbestos fibers. Free Radic. Biol. Med. 1996; 21(4): 487-93.
  109. Galvez, J., Cruz, T., Crespo, E., Ocete, M.A., Lorente, M.D., Sanchez de Medina, F., Zarzuelo, A. Rutoside as mucosal protective in acetic acid-induced rat colitis. Planta Med. 1997; 63(5): 409-14.
  110. Cruz, T., Galvez, J. Ocete, M.A., Crespo, M.E., Sanchez de Medina, L.-H.F., Zarzuelo, A. Oral administration of rutoside can ameliorate inflammatory bowel disease in rats. Life Sci. 1998; 62(7): 687-95.
  111. Kostyuk, V.A., Potapovich, A.I. Antiradical and chelating effects in flavoinoid protection against silica-induced cell injury. Arch. Biochem. Biophys. 1998 Jul 1; 355(1): 43-8.
  112. Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006 Oct;20(10):859-64.
  113. Eliaz I, Weil E, Wilk B. Integrative medicine and the role of modified citrus pectin/alginates in heavy metal chelation and detoxification--five case reports. Forsch Komplementmed. 2007 Dec;14(6):358-64.
  114. Guo M, Perez C, Wei Y, et al. Iron-binding properties of plant phenolics and cranberry’s bio-effects. Dalton Trans. 2007 Nov 21 (43):4951-61.
  115. Mladenka P, Macakova K, Filipsky T, et al. In vitro analysis of iron chelating activity of flavonoids. J Inorg Biochem. 2011 May;105(5):693-701.
  116. Sestili P, Guidarelli A, Dacha M, Cantoni O. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic Biol Med. 1998 Jul 15;25(2):196-200.
  117. Cheng IF, Breen K. On the ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex. Biometals. 2000 Mar;13(1):77-83.
  118. Chander V, Singh D, Chopra K. Reversal of experimental myoglobinuric acute renal failure in rats by quercetin, a bioflavonoid. Pharmacology. 2005 Jan;73(1):49-56.
  119. Zhang Y, Li H, Zhao Y, Gao Z. Dietary supplementation of baicalin and quercetin attenuates iron overload induced mouse liver injury. Eur J Pharmacol. 2006 Mar 27;535(1-3):263-9.
  120. Zhang Y, Gao Z, Liu J, Xu Z. Protective effects of baicalin and quercetin on an iron-overloaded mouse: comparison of liver, kidney and heart tissues. Nat Prod Res. 2011 Jul;25(12):1150-60.
  121. Kulkarni AP, Mahal HS, Kapoor S, Aradhya SM. In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J Agric Food Chem. 2007 Feb 21;55(4):1491-500.
  122. Jiao Y, Wilkinson J 4th, Christine Pietsch E, et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006 Apr 1;40(7):1152-60.
  123. Dairam A, Fogel R, Daya S, Limson JL. Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. J Agric Food Chem. 2008 May 14;56(9):3350-6.
  124. Jiao Y, Wilkinson Jt, Di X, et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. 2009 Jan 8;113(2):462-9.
  125. Thephinlap C, Phisalaphong C, Lailerd N, et al. Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids. Med Chem. 2011 Jan;7(1):62-9.
  126. Baum L, Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models. J Alzheimers Dis. 2004 Aug;6(4):367-77; discussion 443-9.
  127. Thephinlap C, Phisalaphong C, Fucharoen S, Porter JB, Srichairatanakool S. Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice. Med Chem. 2009 Sep;5(5):474-82.
  128. Srichairatanakool S, Thephinlap C, Phisalaphong C, Porter JB, Fucharoen S. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Med Chem. 2007 Sep;3(5):469-74.
  129. Yamanaka, K., Hayashi, H., Tachikawa, M., Kato, K., Hasegawa, A., Oku, N., Okada, S. Metabolic methylation is a possible genotoxicity-enhancing process of inorganic arsenics. Mutat. Res. 1997 Nov 27; 394(1-3): 95-101.
  130. Goering, P.L., Aposhian, H.V., Mass, M.J., Cebrian, M., Beck, B.D, Waalkes, M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 1999 May; 49(1): 5-14.
  131. Gubrelay, U., Mathur, R., Kannan, G.M., Flora, S.J. Role of S-adenosyl-L-methionine in potentiating cadmium mobilization by diethylenetriamine penta acetic acid in mice. Cytobios 2001; 104(406): 99-105.
  132. Paredes, S.R., Kozicki, P.A., Batlle, A.M. S-Adenosyl-L-methionine: a counter to lead intoxication? Comp. Biochem. Physiol. B 1985; 82(4): 751-7.
  133. Skottova, N., Krecman, V., Simanek, V. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Phytother. Res. 1999 Sep; 13(6): 535-7.
  134. Pietrangelo, A., Borella, F., Casalgrandi, G., Montosi, G., Ceccarelli, D., Gallesi, D., Giovannini, F., Gasparetto, A., Masini, A. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 1995 Dec; 109(6): 1941-9.
  135. Wellington, K., Jarvis, B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001; 15(7): 465-89.
  136. Gonzalez-Correa, J.A., de la Cruz, J.P., Gordillo, J., Urena, I., Redondo, L., Sanchez de la Cuesta, F. Effects of silymarin MZ-80 on hepatic oxidative stress in rats with biliary obstruction. Pharmacology 2002 Jan; 64(1): 18-27.
  137. Tager, M., Dietzmann, J., Thiel, U., Hinrich Neumann, K., Ansorge, S. Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin. Free Radic. Res. 2001 Feb; 34(2): 137-51.
  138. Sonnenbichler, J., Goldberg, M., Hane, L., Madubunyi, I., Vogl, S., Zetl, I. Stimulatory effect of silibinin on the DNA synthesis in partially hepatectomized rat livers: non-response in hepatoma and other malign cell lines. Biochem. Pharmacol. 1986 Feb 1; 35(3): 538-41.
  139. Valenzuela, A., Garrido, A. Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin. Biol. Res. 1994; 27(2): 105-12.
  140. Sonnenbichler, J., Scalera, F., Sonnenbichler, I., Weyhenmeyer, R. Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J. Pharmacol. Exp. Ther. 1999 Sep; 290(3): 1375-83.
  141. Beers, M.H., Berkow, M.D. The Merck Manual of Diagnosis and Therapy. Section 23. Chapter 307. Poisoning 1999. Whitehouse Station, NJ: Merck & Co.